F. Ng

发表

Structure-activity relationship studies of ultra-short peptides with potent activities against fluconazole-resistant Candida albicans.

Shawn Hoon, Mohammad Alfatah, Kiat Whye Kong, 2018, European journal of medicinal chemistry.

Preliminary investigations into developing all‐D Omiganan for treating Mupirocin‐resistant MRSA skin infections

Jeffrey Hill, S. M. S. Ng, Qiu Ying Lau, 2017, Chemical biology & drug design.

Antifungal peptides: a potential new class of antifungals for treating vulvovaginal candidiasis caused by fluconazole‐resistant Candida albicans

S. M. S. Ng, Qiu Ying Lau, F. Ng, 2017, Journal of peptide science : an official publication of the European Peptide Society.

Application of Fragment-Based Drug Discovery against DNA Gyrase B.

A. Poulsen, Qiu Ying Lau, F. Ng, 2015, ChemPlusChem.

Screening for a Potent Antibacterial Peptide to Treat Mupirocin-Resistant MRSA Skin Infections

S. M. S. Ng, Qiu Ying Lau, F. Ng, 2017, International Journal of Peptide Research and Therapeutics.

Discovery of an ultra-short linear antibacterial tetrapeptide with anti-MRSA activity from a structure-activity relationship study.

Qiu Ying Lau, F. Ng, Jeffrey Hill, 2015, European journal of medicinal chemistry.

Loss of PYCR2 Causes Neurodegeneration by Increasing Cerebral Glycine Levels via SHMT2

H. Kayserili, H. Hamada, J. Grandjean, 2020, Neuron.

Designing a leucine‐rich antibacterial nonapeptide with potent activity against mupirocin‐resistant MRSA via a structure–activity relationship study

F. Ng, E. H. Ong, C. Chia, 2021, Chemical biology & drug design.

Chemostat studies on the regulation of glucose metabolism in Pseudomonas aeruginosa by citrate.

F. Ng, E. Dawes, 1973, The Biochemical journal.

Identification of an Ultra-Short Peptide with Potent Pseudomonas aeruginosa Activity for Development as a Topical Antibacterial Agent

S. M. S. Ng, F. Ng, J. Teo, 2019, International Journal of Peptide Research and Therapeutics.

Structural insights into phenylethanolamines high-affinity binding site in NR2B from binding and molecular modeling studies

Matthew T. Geballe, J. Snyder, S. Traynelis, 2008, Molecular Brain.

Mapping the high‐affinity binding domain of 5‐substituted benzimidazoles to the proximal N‐terminus of the GluN2B subunit of the NMDA receptor

F. Ng, C. Low, X-K Wee, 2010, British journal of pharmacology.

A Head-to-Head Comparison of the Antimicrobial Activities of 30 Ultra-Short Antimicrobial Peptides Against Staphylococcus aureus, Pseudomonas aeruginosa and Candida albicans

Jeffrey Hill, Qiu Ying Lau, F. Ng, 2015, International Journal of Peptide Research and Therapeutics.

Designing an ultra‐short antibacterial peptide with potent activity against Mupirocin‐resistant MRSA

S. M. S. Ng, Qiu Ying Lau, F. Ng, 2018, Chemical biology & drug design.

Repurposing Zidovudine in combination with Tigecycline for treating carbapenem-resistant Enterobacteriaceae infections

S. M. S. Ng, J. M. Yap, F. Ng, 2017, European Journal of Clinical Microbiology & Infectious Diseases.

Regulation of enzymes of glucose metabolism by citrate in Pseudomonas aeruginosa.

F. Ng, E. Dawes, 1967, The Biochemical journal.

A P2 and P3 substrate specificity comparison between the Murray Valley encephalitis and West Nile virus NS2B/NS3 protease using C-terminal agmatine dipeptides

F. Ng, Jeffrey Hill, J. Joy, 2014, Peptides.

Antiviral activities of peptide-based covalent inhibitors of the Enterovirus 71 3C protease

J. Chu, Jianhe Peng, W. Hong, 2016, Scientific Reports.

Chemical Therapeutics Identi fi cation and Characterization of a Small-Molecule Inhibitor of Wnt Signaling in Glioblastoma Cells

C. Giordano, A. Caricasole, F. Ng, 2013 .

Fragment-based ligand design of novel potent inhibitors of tankyrases.

P. Nordlund, A. Poulsen, F. Ng, 2013, Journal of medicinal chemistry.

Pseudomonas aeruginosa develops Ciprofloxacin resistance from low to high level with distinctive proteome changes.

Jeffrey Hill, Jianhe Peng, F. Ng, 2017, Journal of proteomics.

Discovery of dual GyrB/ParE inhibitors active against Gram-negative bacteria.

Shi Hua Ang, G. Basarab, A. Poulsen, 2018, European journal of medicinal chemistry.

An FDA-Drug Library Screen for Compounds with Bioactivities against Meticillin-Resistant Staphylococcus aureus (MRSA)

Qiu Ying Lau, F. Ng, E. H. Ong, 2015, Antibiotics.

Elucidating the bactericidal mechanism of action of the linear antimicrobial tetrapeptide BRBR-NH2.

C. Verma, Qiu Ying Lau, F. Ng, 2018, Biochimica et biophysica acta. Biomembranes.

Escherichia coli Topoisomerase IV E Subunit and an Inhibitor Binding Mode Revealed by NMR Spectroscopy*

J. Cherian, F. Ng, Jeffrey Hill, 2016, The Journal of Biological Chemistry.

Characterization of the interaction between Escherichia coli topoisomerase IV E subunit and an ATP competitive inhibitor.

J. Cherian, F. Ng, Jeffrey Hill, 2015, Biochemical and biophysical research communications.

Expression and characterization of soluble amino‐terminal domain of NR2B subunit of N‐methyl‐d‐aspartate receptor

S. Traynelis, F. Ng, L. Lim, 2005, Protein science : a publication of the Protein Society.

Peptidomimetic ethyl propenoate covalent inhibitors of the enterovirus 71 3C protease: a P2–P4 study

J. Chu, Jianhe Peng, A. Poulsen, 2016, Journal of enzyme inhibition and medicinal chemistry.

Improving solubility of NR2B amino-terminal domain of N-methyl-d-aspartate receptor expressed in Escherichia coli.

Matthew T. Geballe, F. Ng, C. Low, 2007, Biochemical and biophysical research communications.

Identification of an Ultra-Short Peptide with Potent Pseudomonas aeruginosa Activity for Development as a Topical Antibacterial Agent

S. M. S. Ng, F. Ng, J. Teo, 2018, International Journal of Peptide Research and Therapeutics.

Miniature bovine pancreatic trypsin inhibitors (m-BPTIs) of the West Nile virus NS2B-NS3 protease

A. Poulsen, F. Ng, Jeffrey Hill, 2016, Journal of enzyme inhibition and medicinal chemistry.